2-Naphthalenamine, N-ethyl-1-[[4-(phenylazo)phenyl]azo]- – (6368-72-5)

Pramocaine, pramoxine, 140-65-8, pramocainum, Proxazocain, 4-[3-(4-Butoxyphenoxy)propyl]morpholine, Tronopthane, Pramocaina, 4-(3-(p-Butoxyphenoxy)propyl)morpholine, p-Butoxyphenyl gamma-morpholinopropyl ether, gamma-Morpholinopropyl 4-n-butoxyphenyl ether, CHEBI:8357, Pramocainum [INN-Latin], Pramocaina [INN-Spanish], EINECS 205-425-7, Morpholine, 4-(3-(p-butoxyphenoxy)propyl)-, BRN 0239059, UNII-068X84E056, 068X84E056, DTXSID8040692, 4-27-00-00127 (Beilstein Handbook Reference), Pramocaine (INN), 4-(3-(4-butoxyphenoxy)propyl)morpholine, PRAMOCAINE [INN], Pramocainum (INN-Latin), Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-, Pramocaina (INN-Spanish), Pramocaine [INN:BAN], NCGC00016529-01, CAS-637-58-1, PX9, Spectrum_001380, PRAMOXINE [MI], Prestwick0_000716, Prestwick1_000716, Prestwick2_000716, Prestwick3_000716, Spectrum2_000030, Spectrum3_000925, Spectrum4_001024, Spectrum5_001511, PRAMOXINE [VANDF], CHEMBL1198, PRAMOCAINE [WHO-DD], SCHEMBL26020, BSPBio_000931, KBioGR_001547, KBioSS_001860, DivK1c_000882, SPBio_000099, SPBio_002852, BPBio1_001025, DTXCID6020692, KBio1_000882, KBio2_001860, KBio2_004428, KBio2_006996, KBio3_001930, C05AD07, D04AB07, NINDS_000882, BDBM50225493, DB09345, IDI1_000882, NCGC00016529-02, NCGC00016529-03, NCGC00016529-04, LS-14605, SBI-0051653.P002, 4-[3-(4-Butoxyphenoxy)propyl]morpholine #, AB00053605, Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-, NS00000592, p-Butoxyphenyl .gamma.-morpholinopropyl ether, .gamma.-Morpholinopropyl 4-n-butoxyphenyl ether, C07892, D08407, AB00053605_13, AB00053605_14, EN300-18530975, Q1240076, BRD-K46523383-003-04-7, BRD-K46523383-003-21-1, BRD-K46523383-003-22-9, 205-425-7